Stephen M. Overholser

The University of Texas at San Antonio Health Science Center

Papers

1

Total Citations

33

H-Index

1

About

Dr. Stephen M. Overholser is a urologic surgeon whose research centers on optimizing perioperative pain management and enhancing recovery after minimally invasive surgery. His most impactful work directly addresses the critical balance between clinical efficacy and cost-effectiveness in surgical analgesia. In his landmark 2015 randomized controlled trial, Dr. Overholser compared standard 0.25% bupivacaine against the significantly more expensive long-acting liposomal bupivacaine for pain control in laparoscopic urologic procedures. This study, which has garnered 33 citations, provided pivotal evidence that the premium-priced liposomal formulation did not offer superior pain relief compared to the traditional, cost-effective alternative. By rigorously challenging the routine adoption of costly new technologies without proven benefit, Dr. Overholser’s contributions have helped guide evidence-based, value-conscious surgical practice. His work is essential reading for urologists and anesthesiologists seeking to improve patient outcomes while managing healthcare expenditures, establishing him as a key voice in the ongoing dialogue on surgical quality and resource stewardship.

Research Focus

Key Achievements

1
H-Index
1
Papers
33
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
A Randomized Controlled Trial for Pain Control in Laparoscopic Urologic Surgery: 0.25% Bupivacaine Versus Long-Acting Liposomal Bupivacaine
33 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: The University of Texas at San Antonio Health Science Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago